BioCryst Pharmaceuticals BCRX License and other revenues — Contract with customer, transaction price

Similar metrics at other companies

CPRXLicense And Other Revenue — Revenue

$47K+124%

INVALicense And Other Revenue — Revenue

$1.46M+167%

NUVBLicense — Revenue

$64.72M+1,999%

DNTHLicense — Revenue

$463K-60.2%

TVTXLicense and collaboration revenue — Contract with Customer, Liability, Revenue Recognized

$718K-50.9%

SUPNLicense — Revenue, remaining performance obligation, variable consideration amount

$470M—

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept bcrx:ContractWithCustomerTransactionPrice.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's license and other revenues — contract with customer, transaction price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's license and other revenues — contract with customer, transaction price?: BioCryst Pharmaceuticals (BCRX) reported license and other revenues — contract with customer, transaction price of $2.4M in Q1 2026.
What does license and other revenues — contract with customer, transaction price mean?: This metric represents the total consideration expected to be received from a customer in exchange for transferring promised goods or services under a specific contract. It serves as a key indicator of the total contract value and the potential revenue pipeline generated from strategic collaborations. Tracking this helps investors understand the magnitude of future economic benefits tied to specific partnership agreements.